Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

CSL calls Tavneos withdrawal in Europe a 'significant headwind' for sales

Tavneos’ withdrawal from the European market is creating challenges for CSL Vifor. CSL Limited, Vifor’s Australian parent company, said Vifor’s revenue is expected to fall by roughly a quarter in fiscal ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 18 August →